shortagewatch

Home / Genito-urinary system and sex hormones / Choriogonadotropin Alfa

ATC G03GA08 · Gonadotropins

Choriogonadotropin Alfa shortage

As of 2 Nov 2026, Choriogonadotropin Alfa has a reported shortage in 4 of the 15 countries we track (Canada, Ireland, Japan, Australia), covering 5 products from 3 companies.

Countries4/15
Products5packs or presentations
Companies31 listed
Short since29 Feb 20242.7 years ago
Earliest return6 Nov 2026company estimate
Main reasonIncreased demand
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIreland1 product shortAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan2 products shortAustralia1 product short

Timeline

CanadaIrelandJapanAustralia
2025202620282029203020312032OVIDREL (1 pen)OVIDREL (1 pen)Ovitrelle 250 micrograms solution for injectOvitrelle 250 micrograms solution for injection in pre-filled pen注射用HCG3,000単位「F」注射用HCG3,000単位「F」注射用HCG5,000単位「F」注射用HCG5,000単位「F」OVIDREL choriogonadotropin alfa (rch) 250 miOVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pentoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Fuji Pharma2 4554Emd Serono1Merck Europe1

Listed: Fuji Pharma 4554 · Tokyo

Compared with similar medicines

ATC group G03GA · Gonadotropins
Human Menopausal Gonadotrophin5/15Choriogonadotropin Alfa4/15Urofollitropin2/15Chorionic Gonadotrophin1/15Follitropin Alfa1/15

Affected products

CountryProductCompanySinceExpected backReason
CAOVIDREL (1 pen)EMD SERONO, A DIVISION OF EMD INC., CANADA2 Sep 202430 Dec 2026Increased demand
Demand increase for the drug
IEOvitrelle 250 micrograms solution for injection in pre-filled penMerck Europe B.V.14 Oct 20266 Nov 2026Increased demand
Unexpected increased demand
注射用HCG3,000単位「F」 limited富士製薬工業29 Feb 2024not givenIncreased demand
注射用HCG5,000単位「F」 limited富士製薬工業9 Apr 2026not givenActive ingredient shortage
Raw material (active ingredient) supply problem
AUOVIDREL choriogonadotropin alfa (rch) 250 microgram/ 0.5mL solution for injection pre-filled pen limited1 Jul 202431 Dec 2031Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.